RETIN-A Drug Profile

Name: tretinoin
Brand: RETIN-A

« Back to Dashboard

Which patents cover Retin-a, and when can generic versions of Retin-a launch?

Retin-a is a drug marketed by Valeant Intl, Valeant Bermuda, and Valeant Pharms North. and is included in seven NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in RETIN-A is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for Tradename: RETIN-A

US Patents:	0
Applicants:	3
NDAs:	7
Suppliers / Packagers: see list	5
Bulk Api Vendors: see list	93
Clinical Trials: see list	9
Patent Applications: see list	9,769
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	RETIN-A at DailyMed

Pharmacology for Tradename: RETIN-A

Ingredient-type	Retinoids
Drug Class	Retinoid

ADD ALERT

Glossary

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Exclusivity Expiration
Valeant Intl	RETIN-A	tretinoin	SOLUTION;TOPICAL	016921-001	Approved Prior to Jan 1, 1982		RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017579-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Pharms North	RETIN-A	tretinoin	CREAM;TOPICAL	017340-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-002	May 10, 2002	AB	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Intl	RETIN-A	tretinoin	SWAB;TOPICAL	016921-002	Approved Prior to Jan 1, 1982		DISCN	No	No	► Subscribe	► Subscribe		► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	017522-001	Approved Prior to Jan 1, 1982	AB1	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017955-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	019049-001	Sep 16, 1988	AB	RX	Yes	Yes	► Subscribe	► Subscribe		► Subscribe
Valeant Intl	RETIN-A-MICRO	tretinoin	GEL;TOPICAL	020475-003	Jan 28, 2014		RX	Yes	Yes	► Subscribe	► Subscribe	Y	► Subscribe
Valeant Intl	RETIN-A MICRO	tretinoin	GEL;TOPICAL	020475-001	Feb 7, 1997	AB	RX	Yes	Yes	► Subscribe	► Subscribe	Y	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RETIN-A

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Pharms North	RETIN-A	tretinoin	CREAM;TOPICAL	017340-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Intl	RETIN-A	tretinoin	SOLUTION;TOPICAL	016921-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017955-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017955-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	017522-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Pharms North	RETIN-A	tretinoin	CREAM;TOPICAL	017340-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	019049-001	Sep 16, 1988	► Subscribe	► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	017522-001	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	019049-001	Sep 16, 1988	► Subscribe	► Subscribe
Valeant Intl	RETIN-A	tretinoin	GEL;TOPICAL	017579-002	Approved Prior to Jan 1, 1982	► Subscribe	► Subscribe

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for RETIN-A

Drugname	Dosage	Strength	RLD	Submissiondate
tretinoin	Gel	0.04%	Retin-A Micro	12/20/2010
tretinoin	Gel	0.1%	Retin-A Micro	7/8/2010

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

DrugPatentWatch Database Preview

RETIN-A Drug Profile

« Back to Dashboard

Summary for Tradename: RETIN-A

Pharmacology for Tradename: RETIN-A

Glossary

Expired Patents for Tradename: RETIN-A

Paragraph IV (Patent) Challenges for RETIN-A

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Get our Free Drug Patent Bulletin